Stockreport

Sanofi-Dynavax: A Conservative Vaccine Deal With Upside Tail Risk [Seeking Alpha]

Dynavax Technologies Corporation  (DVAX) 
Last dynavax technologies corporation earnings: 3/11 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.dynavax.com
PDF SNY strengthens its adult vaccine portfolio with HEPLISAV-B, a commercial hepatitis B vaccine, and gains a long-term option on DVAX's shingles candidate. The acquisit [Read more]